Bosentan: In Pediatric Patients with Pulmonary Arterial Hypertension

By Carter Natalie J.   Keating Gillian M.  

Pediatric Drugs, Vol. 12, Iss. 1, 2010-02 ,pp. : 63-73

Adis International

Access to resources Recommend Favorite

Long-term benefits of bosentan in pulmonary arterial hypertension

By  

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Bosentan: haemodynamic role in pulmonary arterial hypertension

By  

Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Short and long term anti-inflammatory effects of bosentan therapy in patients with pulmonary arterial hypertension: relation to clinical and hemodynamic responses

By Karavolias George K   Georgiadou Panagiota   Gkouziouta Angeliki   Kariofillis Panagiotis   Karabela Georgia   Tsiapras Dimitrios   Sbarouni Eftihia   Chaidaroglou Antigoni   Degiannis Dimitrios   Adamopoulos Stamatis   Voudris Vassilis  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1283-1289

Informa Healthcare

Access to resources Recommend Favorite

Bosentan: A Review of its Use in Pulmonary Arterial Hypertension and Systemic Sclerosis

By Oldfield Vicki   Lyseng-Williamson Katherine A.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 189-208

Adis International

Access to resources Recommend Favorite